Sage Journals: Discover world-class research

Retricted access

Review article

First published 2022-4

Newly approved anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory diffuse large B-cell lymphoma

James A. Davis, Abigail Shockley, Ashley E. Glode

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2021

The use of tafasitamab in diffuse large B-cell lymphoma

Johannes Düll, Max Topp, Gilles Salles

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2004-02

Radiotherapy of CD19 Expressing Daudi Tumors in Nude Mice with Yttrium-90-Labeled Anti-CD19 Antibody

Daniel A. Vallera, Michael Elson, Martin W. Brechbiel [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Research article

First published 2016-6

Placebo-controlled study in neuromyelitis optica—Ethical and design considerations

Bruce AC Cree, Jeffrey L Bennett, Mark Sheehan [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2019-2

Safety and tolerability of inebilizumab (MEDI-551),an anti-CD19 monoclonal antibody,in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised,placebo-controlled,escalating intravenous and subcutaneous dose study

Mark A Agius, Gabriela Klodowska-Duda, Maciej Maciejowski [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2022-5

Long-term efficacy and safety of inebilizumab in neuromyelitis optica spectrum disorder: Analysis of aquaporin-4–immunoglobulin G–seropositive participants taking inebilizumab for ⩾4 years in the N-MOmentum trial

Mary Rensel, Aram Zabeti, Maureen A Mealy [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2020-04

Development of Novel Mouse Monoclonal Antibodies Against Human CD19

Shinji Yamada, Mika K. Kaneko, Yusuke Sayama [...]

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Open access

Review article

First published 2018-12

Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia

J. Michael Savoy, Mary Alma Welch, Patrice E. Nasnas [...]

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2010-02

The Lysosomotropic Agent,Hydroxychloroquine,Delivered in a Biodegradable Nanoparticle System,Overcomes Drug Resistance of B-Chronic Lymphocytic Leukemia Cells In Vitro

Eduardo Mansilla, Gustavo H. Marin, Luis Nuñez [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2017-11

Curing tumor-bearing mice by shifting a Th2 to a Th1 anti-tumor response

Karl Erik Hellstrom, Min Dai, Ingegerd Hellstrom

Human Antibodies

Search results